Suven Pharmaceuticals Ltd gets Form 483 from USFDA for inspection at Casper Pharma Pvt Ltd

The United States Food & Drug Administration (US FDA) has completed the surveillance inspection of Casper Pharma Private Limited in Hyderabad (WOS of Suven Pharmaceuticals Limited). The inspection took place from July 8, 2024, to July 12, 2024. Following the inspection, we have been issued a Form 483 with two observations, which are procedural in nature. We are committed to addressing these observations within the stipulated timeline.

Shares of Suven Pharmaceuticals Limited was last trading in BSE at Rs. 848.75 as compared to the previous close of Rs. 855.65. The total number of shares traded during the day was 50561 in over 1439 trades.

The stock hit an intraday high of Rs. 867.45 and intraday low of 836.60. The net turnover during the day was Rs. 42665872.00.

Source : Equity Bulls

Keywords

SuvenPharmaceuticals INE03QK01018 USFDA Inspection CasperPharma Form483 2Observations